Doloneuron-NT 200 Tablet
Prescription required
Coupons & Offers
Highlights
description
Doloneuron-NT 200 Tablet is a powerful combination medicine formulated to relieve chronic nerve pain and restore neurological comfort.
key benefits
Effectively manages chronic neuropathic pain by calming damaged nerves and regulating pain signaling pathways.
side effects
Dizziness, Drowsiness, Dry mouth, Constipation, Blurred vision, Fatigue and Weight gain
alcohol interaction
Caution
pregnancy interaction
Unsafe
lactation interaction
Unsafe
driving interaction
Unsafe
kidney interaction
Unsafe
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited,Unit 601, Sakti Statesman, 6th floor, Green Glen Layout, No.37/301/34/1, SY.No.34, Ibblur Village, Begur Hobli Bangalore, Karnataka-560103 For Support ReachOut : support+geddit@zeptonow.com
Pharmacy License No.
KA-B61-283317, KA-B61-283318
Manufacturer or Marketer Name
Pulse Pharmaceuticals
Manufacturer or Marketer Address
4F10, Ballad Estates, Tarnaka, Hyderabad - 500017, TS, India
Country of Origin
India
Shelf Life
24 months
Expires on or after
November 2026
